| Laboratory Section - Salivary Hormone Testing
for Menopause and Aging
| Topic: Salivary Hormone Testing
for Menopause and Aging |
Date of Origin: 05/06/2003 |
| Section: Laboratory |
Policy No: 36 |
| Approved Date: 05/12/2009 |
Effective Date: 06/01/2009 |
| Next Review Date: 06/2012 |
|
| |
IMPORTANT REMINDER
Regence Medical Policies are developed to provide guidance for members and providers regarding
coverage in accordance with contract terms. Benefit determinations are based in all cases on
the applicable contract language. To the extent there may be any conflict between the Medical
Policy and contract language, the contract language takes precedence.
PLEASE NOTE: Contracts exclude from coverage, among other things, services or procedures that
are considered investigational or cosmetic. Providers may bill members for services or
procedures that are considered investigational or cosmetic. Providers are encouraged to inform
members before rendering such services that the members are likely to be financially responsible
for the cost of these services.
Description
For several decades, there has been interest in testing
various hormone levels using saliva as the specimen
rather than blood, plasma or urine. Salivary testing
has been viewed as potentially more advantageous due
to its noninvasive nature and the relative ease and
convenience of sample collection, which can be done
in the home.
Consumers now have the ability to order home saliva
tests over the Internet for some hormones such as estrogen,
progesterone, testosterone, melatonin, cortisol, and
dehydroepiandrosterone (DHEA). A physician's prescription
is not required for these saliva tests, which are primarily
promoted for the evaluation of menopause and aging.
Policy/Criteria
Salivary hormone testing for the screening, diagnosis
and/or monitoring of menopause and aging is considered
investigational; salivary hormone tests for aging and
menopause include but are not limited to:
- Cortisol
- DHEA
- Estrogen
- Melatonin
- Progesterone
- Testosterone
Scientific Background
Validation of any new diagnostic technique involves
the following steps:
- Technical feasibility of the test must be demonstrated,
including assessment of its reproducibility and precision.
For comparison among studies, a common standardized
protocol is necessary.
Hormone concentrations in saliva are subject to
a number of factors, which influence their correlation
with the total plasma concentration, or the unbound
("free") fraction of hormone. Such factors
include: binding affinity for specific protein
carriers; saliva flow; use of pharmacologic agents,
which may disturb the ratio of free to bound hormone
by displacing the bound hormone; metabolism of
the hormone by salivary gland epithelial cells
or oral bacteria; circadian rhythms; and contamination
of the saliva specimen with blood, food, gingival
fluid or tissue debris. (1,2) Despite these variables,
the technical feasibility of measuring some salivary
hormone levels has been demonstrated in some published
studies; however, it is not clear that standardized
protocols for measuring salivary hormone levels
are used. (1,3) There also continues to be a need
for a protocol for sample collection and handling.
Whembolua and colleagues studied the saliva sample
of 19 healthy adults who provided saliva samples
upon rising in the morning, rinsed their mouths
with water, and donated a second specimen ten minutes
later. (4) Samples were either left untreated or
passed through a 0.22-microm filter and then frozen
at -80 degrees C or incubated at room temperature
for ten days. Aliquots of each sample were cultured
on agar to determine baseline and post-incubation
(or freezing) bacteria load. Bacteria counts
were not significantly influenced by rinsing (with
water), were substantially reduced by filtration,
and increased by incubation at room temperature.
Average levels of salivary testosterone and cortisol,
but not DHEA, were significantly lower in samples
stored at room temperature than samples frozen the
day of collection. The change in bacteria count induced
by storing samples at RT was associated with a change
in testosterone but not cortisol or DHEA. When
samples were passed through a 0.22-microm filter
bacteria counts were reduced, and the association
between bacteria and testosterone was reduced to
non-significant. These findings contribute to a growing
body of literature revealing that the process of
sample collection, storage, and handling can dramatically
influence the accuracy of information generated when
salivary biomarkers are integrated into research
and clinical diagnostics.
- Normal and abnormal values as studied in different
clinical situations must be established. For accurate
interpretation of study results, sensitivities, specificities,
and positive and negative predictive values compared
to a gold standard must be known.
There are no published studies documenting sensitivity,
specificity, or positive and negative predictive
values for any salivary hormones when used to diagnose,
treat or monitor menopause or aging.
- The clinical utility of both positive and negative
tests must be established. The clinical utility of
a diagnostic technique is related to how the results
of that study can be used to benefit patient management.
Relevant outcomes of a negative test (i.e., suspected
pathology is not present) may be avoidance of more
invasive diagnostic tests or avoidance of ineffective
therapy. Relevant outcomes of a positive test (i.e.,
suspected outcome is present) may also include avoidance
of a more invasive test plus the institution of specific,
effective therapy.
There are no published clinical trials that demonstrate
how the results of salivary hormone testing can
be used clinically to direct patient treatment
of menopause or aging. In addition, clinical practice
guidelines from the North American Menopause Society
and the Institute for Clinical Systems Improvement
consider evidence to be insufficient to consider
salivary hormone testing reliable. (8,9) The American
College of Obstetrics and Gynecologists states
that "salivary hormone level testing used
by proponents to “tailor” this therapy
isn't meaningful because salivary hormone levels
vary within each woman depending on her diet, the
time of day, the specific hormone being tested,
and other variables". (10) There are no published
national practice guidelines that advocate the
use of salivary hormone testing in the diagnosis,
treatment or monitoring of menopause or aging.
In summary, there is insufficient evidence in the
published scientific literature to permit conclusions
concerning the use of salivary hormone testing for
the diagnosis, treatment or monitoring of menopause
and aging. An updated search of the MEDLINE database
through February 11, 2009 identified no new published
data that alter this conclusion.
References
- Saliva as a diagnostic fluid. Conference proceedings.
Panama City Beach, Florida, October 22-25, 1992. Ann
N Y Acad Sci 1993;694:1-348
- Lawrence HP. Salivary markers of systemic disease:
noninvasive diagnosis of disease and monitoring of
general health. J Can Dent Assoc 2002;68(3):170-4
- Vining RF, McGinley RA. The measurement of hormones
in saliva: possibilities and pitfalls. J Steroid
Biochem 1987;27(1-3):81-94
- Whembolua GL, Granger DA, Singer S, et al. Bacteria
in the oral mucosa and its effects on the measurement
of cortisol, dehydroepiandrosterone, and testosterone
in saliva. Horm Behav. 2006;49(4):478-83
- Rakel, David. Integrative Medicine 1st edition.
Philadelphia: Elsevier Science 2003
- Thiedke CC. Menopause. Clinics in Family Practice.
2002;4(4):1-16
- Boothby LA, Doering PL, Kipersztok S. Bioidentical
hormone therapy: a review. Menopause 2004;11(3):356-67
- The American Menopause Society. The role of testosterone
therapy in postmenopausal women: position statement
of the North American Menopause Society. Menopause 2005;12(5):497-511
- Institute
for Clinical Systems Improvement (ISCI). Menopause
and hormone therapy (HT): collaborative decision-making
and management. 2008;64:198 (Verified 2/11/09)
- ACOG News Release: ACOG Reiterates Stance on So-Called “Bioidentical” Hormones.
The American College of Obstetrics and Gynecologists;
2009 http://www.acog.org/from_home/publications/press_releases/nr02-03-09.cfm (Verified
2/11/09)
Cross References
None
| Codes |
Number |
Description |
| CPT |
82530 |
Cortisol; free |
| |
82626 |
Dehydroepiandrosterone (DHEA) |
| |
82627 |
Dehydroepiandrosterone-sulfate (DHEA-S) |
| |
82670 |
Estradiol |
| |
82677 |
Estriol |
| |
82679 |
Estrone |
| |
84144 |
Progesterone |
| |
84402 |
Testosterone; free |
| HCPCS |
S3650 |
Saliva test, hormone level; during menopause |
Laboratory Section Table of Contents 

|